Manufacturer Release 012
Guidance for : At the end of every calendar quarter, we continue to experience difficulty in receiving pricing data from a number of participating drug labelers. Additionally, we have encountered many instances where data for selected drug products have not been submitted.
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: June 29, 1994
HHS is committed to making its websites and documents accessible to the widest possible audience, including individuals with disabilities. We are in the process of retroactively making some documents accessible. If you need assistance accessing an accessible version of this document, please reach out to the guidance@hhs.gov.
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.